1Hui MC. Cancer pain management[J], the Medical Clinics of North America, 1999,83 (3) : 711-736.
2McCaffery M,Pasero C.Using the 0-10 pain rating scale[J]. Am J Nars, 2001,101 ( 10 ) : 81-82.
同被引文献10
1Suzuki T. Treatment of cancer pain and medical narcotics[J]. Yakugaku Zasshi, 2015, 135(12) : 1325-1334.
2Varilla V, Schneiderman H, Keefe S. Effective pain control with extraordinary opiate dosing in cancer[J]. Conne Medi, 2015, 79(9) : 521-524.
3Panis C, Pavanelli WR. Cytokines as mediators of pain-re- lated process in breast cancer[J]. Mediat Inflamm, 2015, 12 (9):34-39.
4Gentili M, Clerico M, Spizzichino M ,et al. Use of a check- list to improve pain control in hospitalized cancer patients[J]. Future Oncol, 2016, 12(2): 199-205.
5Lee J, Lakha SF, Mailis A. Efficacy of low-dose oral liquid morphine for elderly patients with chronic non-cancer pain: retrospective chart review[J]. Drugs Outcome, 2015, 2(4): 369-376.
6Hopkins KG, Hoffman LA, Dabbs Ade V , et al. Postthora- cotomy pain syndrome following surgery for lung cancer: symptoms and impact on quality of life[J]. Jour Advan Onco, 2015, 6(2): 121-132.
7Prommer EE. Pharmacological management of cancer-relat- ed pain[J]. J Canc Cent, 2015, 22(4):412-425.
8Yan XB, Peng TC, Huang D. Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer[J]. Onco Targets Ther, 2015, 12(8) : 3703-3706.
